BioNxt Solutions

Activities: Drug Delivery Dosage Forms

Trending Articles

  1. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  2. Tablet-in-capsule technology: a versatile platform for complex oral solid dose development Tablet-in-capsule technology is redefining oral solid dosage development by enabling modular formulation design, differentiated release profiles and efficient fixed-dose...
  3. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for...
  4. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global...
  5. Viatris to cut 10% of its global workforce after Indian plant fire Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected...

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

Related Content

Drug Delivery

BioNxt signs agreement to acquire novel solid oral drug dosage tech

"This coating system could significantly improve oral tablet and oral capsule drug delivery with more precise drug release and predictable dosing."
Subscribe now